Literature DB >> 24334168

Low grade cirrhosis induces cognitive impairment and motor dysfunction in rats: could be a model for minimal hepatic encephalopathy.

Santosh Singh1, S K Trigun2.   

Abstract

Hepatic encephalopathy (HE) is a nervous system disorder developed in the patients with liver cirrhosis. The low grade cirrhosis is of common occurrence, however, whether and the extent to which it affects brain function is not clearly understood. The present article examines certain neurobehavioral parameters in the rats with low grade chronic liver failure (CLF) induced by intraperitoneal administration of 50mg/kgb.w. thioacetamide up to 14 days. During Morris Water Maze tasks, the CLF rats, as compared to the control, showed insignificant decline in the escape latency score to find out the hidden platform throughout the learning days and also stayed for a significantly declined (p<0.01) time period at the place of the hidden platform during the retrieval test. They also showed impairment in the conditional discrimination ability, reflected by a significant decline in the active avoidance score (p<0.05) and increment in the number of non-response (p<0.05) during shuttle box tests. On rotarod performance, they exhibited significant decline in their riding time (p<0.01-001) on the rotating rod as a function of increasing speed. The findings suggest a moderate level cognitive impairment and motor dysfunction in the low grade CLF rats. Since, these impairments correlate with the early stage manifestation of HE in the patients, these CLF rats could serve as a model to study the pathogenesis of minimal hepatic encephalopathy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Low grade cirrhosis; Minimal hepatic encephalopathy; Motor dysfunction

Mesh:

Year:  2013        PMID: 24334168     DOI: 10.1016/j.neulet.2013.11.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

2.  Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.

Authors:  H A Murad; Z J Gazzaz; S S Ali; M S Ibraheem
Journal:  Braz J Med Biol Res       Date:  2017-09-21       Impact factor: 2.590

3.  Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4.

Authors:  Farouk K El-Baz; Rania Elgohary; Abeer Salama
Journal:  Biomed Res Int       Date:  2021-03-28       Impact factor: 3.411

4.  Bacopa monnieri Extract (CDRI-08) Modulates the NMDA Receptor Subunits and nNOS-Apoptosis Axis in Cerebellum of Hepatic Encephalopathy Rats.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.